Scott Vaspory

Scott Vaspory has a long and varied work experience. Scott began their career in 2004 as Laboratory Staff at Rutgers Cook College. In 2006, they moved to ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, as a Cell Culture Technician III. In 2011, they joined Protein Sciences Corporation as a Process Engineer and Sr Manager of Commercial Manufacturing. In 2020, they became Deputy Director of Recombinant Drug Substance Production at Sanofi Pasteur. Scott's current role is Director of Chemistry Manufacturing and Controls at Airway Therapeutics, which they began in 2022.

Scott Vaspory obtained a B.S. in Biotechnology and Biochemistry from Rutgers University between 2002 and 2006. In 2011, they obtained an ASQ Certified Six Sigma Green Belt certification from ASQ.